"/> Tocris Bioscience™ HHP 9 | B-LABO France

Tocris Bioscience™ HHP 9

Réf. : BL-RE-164975Réf. fabricant : 30000664 5 mg
348,80 € HT

BET bromodomain Degrader (PROTAC™); also potent Hedgehog pathway inhibitor

Nom chimique ou matériau
2-Methoxyethyl 4-(3-((1-(6-((2-(2,6-dioxopiperidin-3-yl)-1,3-dioxoisoindolin-4-yl)oxy)hexyl)-1H-1,2,3-triazol-4-yl)methoxy)phenyl)-7-(2-methoxyphenyl)-2-methyl-5-oxo-1,4,5,6,7,8-hexahydroquinoline-3-carboxylate
Quantité
5 mg
Cible
Active Degraders
Formule moléculaire
C49H52N6O11
Pureté
0.98
Marque
Tocris Bioscience

HHP 9 is a potent BET bromodomain Degrader (PROTAC™; DC50 values are 0.03 μM, 0.2 μM and 0.2 μM at BRD3, BRD2 and BRD4 respectively). BRD2, BRD3 and BRD4 are almost completely degraded by HHP 9

in vitro

(after 27h incubation with 0.5 - 5 μM of HHP 9). Comprises a Hedgehog Pathway Inhibitor-1 ( HPI-1, Cat. No. 3839) coupled to a CRBN ligand. BET bromodomain degradation through HPP-9 results in long-acting Hh pathway inhibition.

PROTAC™ is a registered trademark of Arvinas Operations, Inc., and is used under license.

Caractéristiques techniques

MarqueTocris Bioscience
Réf. B-LABOBL-RE-164975
Réf. fabricant30000664
Nom chimique ou matériau2-Methoxyethyl 4-(3-((1-(6-((2-(2,6-dioxopiperidin-3-yl)-1,3-dioxoisoindolin-4-yl)oxy)hexyl)-1H-1,2,3-triazol-4-yl)methoxy)phenyl)-7-(2-methoxyphenyl)-2-methyl-5-oxo-1,4,5,6,7,8-hexahydroquinoline-3-carboxylate
Quantité5 mg
CibleActive Degraders
Formule moléculaireC<sub>49</sub>H<sub>52</sub>N<sub>6</sub>O<sub>11</sub>
Pureté0.98
Une question, une configuration particulière ?
Contactez-nous pour un devis.